GGrantIndex
← Leaderboards

Joseph P Schacht

University Of Colorado

$7,018,684
Attributed
$9,140,014
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,140,014 · 8

By mechanism

R01$4,143,481 · 2
U01$2,828,440 · 1
R00$746,877 · 1
P50$707,934 · 1
R21$429,000 · 1
K99$208,349 · 1

Top collaborators

Most similar at University Of Colorado

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingCue ReactivityRewardsBrainAlcohol ConsumptionAlcohol CueCorpus Striatum StructureDrinkingDecision MakingCuesPlacebosNeuroimagingPharmaceutical PreparationsDoseParticipantLaboratoriesAchievementAlcoholsAllelesRecruitAlcohol Use DisorderAdvanced DevelopmentFda ApprovedNational Institute On Alcohol Abuse And Alcoholism

Grant awards (22)

Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation$2,828,440
U01 · FY2025 · DA
Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study$353,967
P50 · FY2025 · DA · contact PI
Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study$353,967
P50 · FY2024 · DA · contact PI
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder$460,245
R01 · FY2023 · AA · contact PI
An exploratory randomized controlled trial of the effects of oral semaglutide on alcohol craving and consumption$429,000
R21 · FY2023 · AA · contact PI
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder$330,904
R01 · FY2023 · AA · contact PI
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder$489,925
R01 · FY2022 · AA · contact PI
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder$363,188
R01 · FY2022 · AA · contact PI
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder$489,925
R01 · FY2021 · AA · contact PI
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder$363,188
R01 · FY2021 · AA · contact PI
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder$489,925
R01 · FY2020 · AA · contact PI
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder$363,188
R01 · FY2020 · AA · contact PI
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder$462,555
R01 · FY2019 · AA · contact PI
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder$330,438
R01 · FY2019 · AA · contact PI
Neural Connectivity and the Transition to Alcohol Dependence$248,959
R00 · FY2017 · AA · contact PI
Neural Connectivity and the Transition to Alcohol Dependence$248,959
R00 · FY2016 · AA · contact PI
Neural Connectivity and the Transition to Alcohol Dependence$248,959
R00 · FY2015 · AA · contact PI
Neural Connectivity and the Transition to Alcohol Dependence$96,065
K99 · FY2014 · AA · contact PI
Neural Connectivity and the Transition to Alcohol Dependence$112,284
K99 · FY2013 · AA · contact PI
A Transdisciplinary Approach to Cannabis Addiction$15,187
F31 · FY2008 · DA · contact PI
A Transdisciplinary Approach to Cannabis Addiction$30,373
F31 · FY2007 · DA · contact PI
A Transdisciplinary Approach to Cannabis Addiction$30,373
F31 · FY2006 · DA · contact PI